[CBAY] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
15-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 38.75%
YoY- 27.46%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 0 0 0 5,207 0 0 0 -
PBT -15,751 -29,413 -19,449 -5,043 -6,952 -5,979 -12,722 3.62%
Tax -123 -150 1,106 -543 361 465 -4,759 -45.59%
NP -15,751 -29,413 -19,449 -5,043 -6,952 -5,979 -12,722 3.62%
Tax Rate - - - - - - - -
Total Cost 15,751 29,413 19,449 10,250 6,952 5,979 12,722 3.62%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 0.00 0.00 0.00 -96.85 0.00 0.00 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.23 -0.43 -0.31 -0.09 -0.26 -0.26 -0.84 -19.40%
EPS Diluted -0.23 -0.43 -0.31 -0.09 -0.26 -0.26 -0.84 -19.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.